School of Medicine
Showing 1-16 of 16 Results
-
Donald Regula, MD
Professor (Teaching) of Pathology and, by courtesy, of Orthopaedic Surgery
BioDr. Regula is a course director for the required medical student course, Science of Medicine.
-
Nathan Reticker-Flynn
Instructor, Pathology
BioNathan is a tumor immunologist working in the laboratory of Dr. Edgar Engleman. He works at the interfaces of Systems Biology, mouse models, and cancer immunology where he investigates interactions between tumors and the immune system during cancer metastasis. He performed his PhD work in Biomedical Engineering with Dr. Sangeeta Bhatia at MIT where he studied glycobiology and ECM interactions during cancer metastasis.
-
Pema Richeson
Research Program Manager, Pathology - Montine Lab
Current Role at StanfordProgram Manager | Team eDyNAmiC, Cancer Grand Challenges
Project Manager | PPMI Pathology Core
Center Administrator | Stanford SeroNet Center of Excellence -
Kerri E. Rieger, MD, PhD
Clinical Associate Professor, Pathology
Clinical Associate Professor, DermatologyBioDr. Rieger is a Clinical Associate Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in hospitalized patients and patients with autoimmune disease. She also sees patients in the dermatology clinic at the Stanford Medicine Outpatient Center in Redwood City, where her clinical interest is adult general dermatology.
-
Suman Rimal
Postdoctoral Scholar, Pathology
BioResearch interests: Genetic mechanism underlying mitochondrial pathology, neurodegeneration, and muscle loss using Drosophila as a model organism.
-
Theodore Roth
Affiliate, Dean's Office Operations - Dean Other
Resident in PathologyCurrent Research and Scholarly InterestsScalable technologies for engineering next generation cellular therapies
